Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Return on Equity (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Return on Equity for 6 consecutive years, with 0.45% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 31.0% to 0.45% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.45% through Dec 2025, up 31.0% year-over-year, with the annual reading at 0.56% for FY2025, 35.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.45% at BioScience Health Innovations, down from 0.52% in the prior quarter.
  • The five-year high for Return on Equity was 10.6% in Q3 2023, with the low at 273.07% in Q4 2023.
  • Average Return on Equity over 5 years is 14.75%, with a median of 0.14% recorded in 2024.
  • Peak annual rise in Return on Equity hit 27322bps in 2024, while the deepest fall reached -1047bps in 2024.
  • Over 5 years, Return on Equity stood at 1.13% in 2021, then plummeted by -335bps to 4.92% in 2022, then tumbled by -5453bps to 273.07% in 2023, then soared by 100bps to 0.14% in 2024, then skyrocketed by 213bps to 0.45% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.45%, 0.52%, and 0.64% for Q4 2025, Q3 2025, and Q2 2025 respectively.